Stocks
Funds
Screener
Sectors
Watchlists
DH

DH - Definitive Healthcare Corp. Stock Price, Fair Value and News

$2.36-0.03 (-1.26%)
Market Closed

48/100

DH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

48/100

DH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.44

Target 3M

$2.43

Target 6M

$2.44

DH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

DH Price Action

Last 7 days

-0.8%

Last 30 days

-12.9%

Last 90 days

-11.9%

Trailing 12 Months

-52.9%

DH RSI Chart

DH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

DH Valuation

Market Cap

243.8M

Price/Earnings (Trailing)

-1.28

Price/Sales (Trailing)

1.01

EV/EBITDA

-1.25

Price/Free Cashflow

6.77

DH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.44

Target 3M

$2.43

Target 6M

$2.44

DH Fundamentals

DH Revenue

Revenue (TTM)

242.3M

Rev. Growth (Yr)

-4.23%

Rev. Growth (Qtr)

-1.16%

DH Earnings

Earnings (TTM)

-190.4M

Earnings Growth (Yr)

88.66%

Earnings Growth (Qtr)

-60.15%

DH Profitability

EBT Margin

-116.67%

Return on Equity

-48.86%

Return on Assets

-25.2%

Free Cashflow Yield

14.77%

DH Investor Care

Buy Backs (1Y)

10.58%

Diluted EPS (TTM)

-1.68

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025247.9M244.9M242.3M0
2024255.7M258.5M255.8M252.2M
2023231.7M238.1M246.1M251.4M
2022179.3M194.1M208.4M222.7M
2021128.9M140.5M153.5M166.2M
2020000118.3M
20190000
DH
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing firms and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.
 CEO
 WEBSITEdefinitivehc.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES946

Definitive Healthcare Corp. Frequently Asked Questions


DH is the stock ticker symbol of Definitive Healthcare Corp.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Definitive Healthcare Corp. is 243.8 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check DH's fair value in chart for subscribers.

The fair value guage provides a quick view whether DH is over valued or under valued. Whether Definitive Healthcare Corp. is cheap or expensive depends on the assumptions which impact Definitive Healthcare Corp.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DH.

As of Wed Jan 28 2026, DH's PE ratio (Price to Earnings) is -1.28 and Price to Sales (PS) ratio is 1.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DH PE ratio will change depending on the future growth rate expectations of investors.